The clinical significance of detection of vascular endothelial growth factor and CD44v6 expression in human non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 7, Issue 5, 2004, Pages 427-430

  Zhang, Lin ^a   Meng, Long ^a   Wang, Lei ^a   Peng, Zhongming ^a   Chen, Jinhan ^a   Wang, Zhou ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

CD44v6; Immunohistochemical method; Lung neoplasms; Metastasis; Vascular endothelial growth factor

Indexed keywords

CD44V6 ANTIGEN; VASCULOTROPIN;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; METASTASIS; POSTOPERATIVE CARE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 7444259174     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 1995, 55(18): 3964-3968.
2. Fontanini G, Vignati S, Bigini D, et al. Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer (NSCLC) development. Int J Cancer, 1996, 67(5): 615-619.
3. Takahama M, Tsutsumi M, Tsujiuchi T, et al. Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers. Jpn J Clin Oncol, 1998, 28(3): 176-181.
4. Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res, 1997, 3(6): 861-865.
5. Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer, 2000, 89(6): 475-483.
6. Han H, Silverman JF, Santucci TS, et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol, 2001, 8(1): 72-79.
7. Wang ZT, Zhang HQ, Li SY. Expression and clinical significance of nm23-H1 and CD44v6 in non-small cell lung cancer. Chin J Lung Cancer, 2002, 5(4): 278-281.
8. Wimmel A. Kogan E, Ramaswamy A, et al. Variant expression of CD44 in preneoplastic lesions of the lung. Cancer, 2001, 92(5): 1231-1236.
9. Penno MB, August JT, Baylin SB, et al. Expression of CD44 in human lung tumors. Cancer Res, 1994, 54(5): 1381-1387.
10. Jackson DG, Schenker T, Waibel R, et al. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer Suppl, 1994, 8: 110-115.
11. Wimmel A, Schilli M, Kaiser U, et al. Preferential histiotypic expression of CD44-isoforms in human lung cancer. Lung Cancer, 1997, 16(2-3): 151-172.
12. Ramasami S, Kerr KM, Chapman AD, et al. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. J Pathol, 2000, 192(4): 427-432.
13. Miyoshi T, Kondo K, Hino N, et al. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Clin Cancer Res, 1997, 3(8): 1289-1297.
14. Hirata T, Fukuse T, Naiki H, et al. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res, 1998, 58(6): 1108-1110.
15. Wang YP. Molecular mechanism of invasion and metastasis in lung cancer. In: Zhou QH, Sun Y, Ed. Advanced of new theories and techniques in lung cancer. Chengdu: Publishing House of Sichuan University, 2003, 90-110.
16. Griffioen AW, Coenen MJ, Damen CA, et al. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood, 1997, 90(3): 1150-1159.